One Amazing Story
1950-1960
Industry
- Chemical structure of DNA discovered
LabCorp
- Biomedical Laboratories founded
in Burlington, North Carolina
1970-1974
Industry
- First regional Tay-Sachsscreening program implemented
LabCorp
- First scientific specialist joins LabCorp
1975-1979
Industry
- NIH sets age 35 and above as
"advanced maternal age" where
amniocentesis should be offered
LabCorp
- Chromosome analysis begins
1980-1984
Industry
- First case of AIDS reported in US
- Polymerase chain reaction technology
developed
LabCorp
- AFP screening offered
- AIDS testing begins
1985-1989
Industry
- Human genome sequence effort launched
LabCorp
- Center for Molecular Biology & Pathology
(CMBP) for molecular-based lab services started
1990-1994
Industry
- ID of genes involved in development of cancers- ID of genes associated with disorders
such as Fragile X
LabCorp
- Oncology testing program launched
- Molecular oncology, molecular genetic testing
introduced
- Clinical trials in molecular testing procedures
in infectious diseases and oncology performed
- Mitochondrial DNA testing for forensic ID
introduced
1995-1999
Industry
- FDA approves Amplicor HIV-Viral Load Kit
- FDA approves targeted immunotherapy for breast cancer, Herceptin
- ACOG recognizes 3 marker screenings as standard of care
LabCorp
- Genetic Design purchased
- Hepatitis C genotyping introduced
- HIV GeneChip technology for HIV genotype studies;
genotyping and phenotyping and correlation database introduced
- Partnership with Virco
- Automated PCR testing introduced
2000-2004
Industry
- Human genome sequenced
- ACOG publishes cystic fibrosis testing recommendations
LabCorp
- National Genetics Institute, ViroMed Laboratories and Dianon acquired
- Partnership with EXACT Sciences, Celera Diagnostics,
Myriad Genetics, Correlogic Systems, and BioPredictive
- Genosure, PreGen Plus introduced
- Expansion of molecular testing menu
LabCorp Today
LabCorp, an S&P 500 company, is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $4.7 billion in 2009, more than 28,000 employees worldwide, and more than 220,000 clients, LabCorp offers clinical assays ranging from routine blood analyses to HIV and genomic testing. LabCorp combines its expertise in innovative clinical testing technology with its specialty laboratories: The Center for Molecular Biology and Pathology, The National Genetics Institute, Inc., ViroMed Laboratories, Inc., Litholink Corporation, DIANON Systems, Inc., US LABS, Dynacare Laboratories, and Esoterix and its Colorado Coagulation, Endocrine Sciences, and Cytometry Associates laboratories. LabCorp conducts clinical trial testing through its Esoterix Clinical Trials Services division. LabCorp clients include physicians, government agencies, managed care organizations, hospitals, clinical labs, and pharmaceutical companies
